Scarica l'app Stockscreener
3.03
5.90%
-0.19
Pre-mercato:
3.02
-0.010
-0.33%
Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie
Published on: 2026-04-13 23:21:17 - baoquankhu1.vn
Guidance Update: Is Cyclerion Therapeutics Incs growth already priced inEarnings Recap Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
CYCN stock is soaring 150% pre-market today — what is fueling the rally? - MSN
Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders? - Finviz
Fed Watch: Is Cyclerion Therapeutics Incs growth already priced inQuarterly Earnings Summary & AI Optimized Trade Strategies - baoquankhu1.vn
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cyclerion Therapeutics, Inc. (Nasdaq – CYCN), National Storage Affiliates (NYSENSA), Urgent.ly, Inc. (OTC MarketsULYX), UniFirst Corporation (NYSEU - ChartMill
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
Rate Hike: Is Cyclerion Therapeutics Incs growth already priced in2026 Historical Comparison & Expert Approved Momentum Ideas - baoquankhu1.vn
Halper Sadeh LLC is Investigating Whether SLNO, FORA, MKC, CYCN are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
Alzheimer’s company Korsana heads to NASDAQ via merger: Deals Report - biocentury.com
CYCN Stock Price, Quote & Chart | CYCLERION THERAPEUTICS INC (NASDAQ:CYCN) - ChartMill
Penny stock CYCN surged more than 300% yesterday. Why, and should you chase the rally here? - MSN
CYCN PE Ratio & Valuation, Is CYCN Overvalued - Intellectia AI
CYCN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
If You Invested $1,000 in Cyclerion Therapeutics Inc (CYCN) - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today - Sahm
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) - Sahm
Korsana Biosciences and Cyclerion Therapeutics Announce All-Stock Merger and $380 Million Financing - Global Legal Chronicle
Monteverde & Associates Investigates Cyclerion Therapeutics Merger - National Today
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
CYCN Plunges 17% After Merger Announcement: What’s Next for Cyclerion and Korsana? - Bitget
Cyclerion and Korsana Tie the Knot with a New Merger Strategy - StocksToTrade
Cyclerion Therapeutics Merger Sparks Investor Uncertainty - timothysykes.com
Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here? - Barchart.com
Korsana boosts Alzheimer’s work with reverse merger, $380M financing - BioWorld News
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cycle - The National Law Review
Cyclerion Therapeutics and Korsana Biosciences Announce $380M Merger to Advance Alzheimer’s Treatment KRSA-028 - Minichart
CYCN Stock Explodes 313% on April 1 After Cyclerion-Korsana Merger Deal for Alzheimer's Pipeline - International Business Times Australia
12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders - The Joplin Globe
Cyclerion Therapeutics, Inc. (CYCN) stock price, news, quote and history - Yahoo Finance UK
Cyclerion Therapeutics Merges with Korsana Biosciences in New Agreement - El-Balad.com
Korsana takes its brain shuttle tech public via reverse merger with Cyclerion - FirstWord Pharma
Shareholder Alert: Ademi LLP investigates whether Cyclerion Therapeutics Inc. is obtaining a Fair Price for Public Shareholders - PR Newswire
Korsana Biosciences and Cyclerion Therapeutics to Merge, Operate Under Korsana Name - Contract Pharma
Cyclerion Therapeutics to Merge with Korsana Biosciences - TipRanks
Cyclerion Therapeutics: $380 Million Financing To Merge With Korsana Biosciences And Advance Alzheimer’s Pipeline - Pulse 2.0
Cyclerion Therapeutics (NASDAQ: CYCN) to merge with Korsana, $380M PIPE backing - Stock Titan
Cyclerion to Merge With Korsana; $380 Million PIPE, CVRs and Lock-Ups Support Deal - TradingView
Korsana Biosciences to go public via Cyclerion (CYCN) reverse merger and $380M PIPE - Stock Titan
Korsana Taps Cyclerion For $380M Public Listing In Boston - Hoodline
Best Pharmaceutical Stocks To Follow NowApril 1st - MarketBeat
Promising Medical Stocks To ConsiderApril 1st - MarketBeat
Cyclerion Therapeutics stock soars 350% on Korsana merger, $380 million financing - MSN
Cyclerion provides public listing vehicle for Korsana in $380M deal - The Business Journals
Cyclerion Therapeutics, Inc. (CYCN) Stock: Skyrockets 324% on Blockbuster Korsana Merger Backed by Wall Street's Biggest Names - parameter.io
Crude Oil Down Over 1%; ISM Manufacturing PMI Rises In March - Benzinga
Why is Biotech Stock Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) Gaining? - Investorideas.com
Cyclerion Therapeutics, Korsana Biosciences enter merger agreement - TipRanks
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement - Business Wire
Cyclerion Therapeutics (CYCN) Stock Jumps 160% Following Korsana Biosciences Merger Announcement - MEXC Exchange
Trending Stocks Today | Cyclerion Therapeutics Shoots up 322.9% - Moomoo
Cyclerion Therapeutics and Korsana Biosciences To Merge - citybiz
Cyclerion Therapeutics Stock Soars 350% On Korsana Merger, $380 Million Financing - Benzinga
Cyclerion Therapeutics surges as it agrees to merge with Korsana Biosciences in a deal backed by a large private financing - Quiver Quantitative
Dow Jumps Over 200 Points; Nike Shares Tumble After Q3 Results - Benzinga
Cyclerion Therapeutics (CYCN) Stock Surges 160% on Korsana Merger Deal - MEXC
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):